logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

诺诚健华 香港上市

China biotech InnoCare raises $288 million in Hong Kong IPO: sources

Mar 17, 2020

Life Science

应世生物IN10018

InxMed Announces Dosing of First Patient in a Phase Ib Trial of IN10018 as Monotherapy and Combination Therapy in Patients with Uveal Melanoma and NRAS mutant Metastatic Melanoma in the United States

Mar 17, 2020

Life Science

WELL Health Technologies Corp (TSXV WELL)

WELL Health Applauds Regulatory Changes in British Columbia and Ontario designed to enhance funding for Doctors to support patients due to COVID-19 Pandemic

Mar 17, 2020

Life Science

GTEC Announces Amendments to Acquisition Agreements, Completion of Grey Bruce Farms Harvests and Satisfaction of Milestones

Mar 17, 2020

Life Science

GTEC Enters into Term Sheet for $4.5 Million Debt Financing

Mar 17, 2020

Life Science

BioELife 新冠病毒 CytoDyn PRO 140

Healthcare Roundup – BioELife expands COVID-19 prevention product line, CytoDyn advancing mid-stage study of PRO 140 for COVID-19

Mar 17, 2020

Life Science

Moderna 新冠肺炎 疫苗 试验

First Patient Dosed in Moderna’s COVID-19 Vaccine Trial

Mar 16, 2020

Life Science

赛诺菲再生元Kevzara®新冠病毒

Sanofi and Regeneron begin global Kevzara® (sarilumab) clinical trial program in patients with severe COVID-19

Mar 16, 2020

Life Science

复星 BioNTech 新冠病毒

BioNTech and Fosun to Develop mRNA Vaccine for COVID-19

Mar 16, 2020

Life Science

Aleafia Health Inc. (TSX ALEF)

Aleafia Health Secures Niagara Facility Cultivation Licence

Mar 16, 2020

Life Science

WELL Health Announces Closing of Second Tranche of Upsized $11M Private Placement of Convertible Debentures Including Mr. Li Ka-shing

Mar 16, 2020

Life Science

特朗普 全国紧急状态 新冠病毒 吉利德 瑞德昔韦

Healthcare Roundup – President Trump declares national emergency over coronavirus, Gilead up 6% premarket on encouraging action of remdesivir in COVID-19

Mar 13, 2020

Life Science

辉瑞 销售员 远程工作

Pfizer tells all US salespeople they must work remotely

Mar 13, 2020

Life Science

谷歌将建网站帮助检测新冠病毒

Google is making a coronavirus information site to help find testing as more kits become available

Mar 13, 2020

Technology

WELL Health Provides Corporate Update: Core Clinic and SaaS EMR Revenues Prove to be Resilient and Growing While Telehealth Ramps Up Significantly

Mar 13, 2020

Technology

Predictive Oncology 新冠病毒 Neogen

Healthcare Roundup –Predictive Oncology up 50%,Neogen ramps up production of disinfectants to fight COVID-19

Mar 13, 2020

Life Science

WELL Health Announces Upsize of Private Placement Of Convertible Debentures to $11.0 Million To Include Mr. Li Ka-shing

Mar 13, 2020

Life Science

和铂医药完成7500万美元B+轮融资

Harbour BioMed Secures $85 Million in Financing Round to Support Clinical-Stage Compounds

Mar 12, 2020

Life Science

  • ‹‹ Previous
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada